ESPR · Esperion Therapeutics, Inc.
Market Cap
$818.63M
Shares
257.43M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2023-02-21 | — | $70,000,000 | — | — | 10-K , filed 2026-03-10 |
Repurchase History
| Fiscal Year Ended | Cash Spent | Source | ||
|---|---|---|---|---|
| 2021-12-31 | $0 | 10-K, filed 2022-02-22 | ||
| 2020-12-31 | $55,000,000 | 10-K, filed 2022-02-22 | ||
Key facts
CIK
1434868
CUSIP
29664W105
13F (30d)
180 filings
177 filers
Visit website
Investor relations